Skip to content

Effect of oral and intravenous Tranexamic Acid for preventing postpartum hemorrhage after cesarean delivery

Effect of oral and intravenous Tranexamic Acid for preventing postpartum hemorrhage after cesarean delivery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20151228025732N78
Enrollment
100
Registered
2023-07-06
Start date
2023-07-11
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemorrhage after cesarean delivery. Maternal care for scar from previous cesarean delivery

Interventions

Intervention 1: Intervention group: In this group, according to the protocol, the infusion of one gram of tranexamic acid (two 500 mg TRANEXIP® ampoules manufactured by Caspian Pharmaceutical Company,

Sponsors

Semnan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Age between 18 and 40 years Candidate for non-emergency cesarean section A singleton pregnancy with a gestational age between 38 and 39 weeks that has been confirmed by ultrasound

Exclusion criteria

Exclusion criteria: Preeclampsia, premature birth, prolonged rupture of the water sac, multiple births Visualization of fetal anomalies by ultrasound Previous history of systemic diseases

Design outcomes

Primary

MeasureTime frame
Blood pressure. Timepoint: Before the start of cesarean section and 2 hours after surgery. Method of measurement: Heart monitor device.;Postpartum bleeding volume. Timepoint: The difference in the weight of sheets, gauze and long gauze used during surgery and up to 2 hours after surgery. Method of measurement: "Mahek" brand digital scale (made in Iran with an accuracy of 0.1 gr).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSati Nik Darzi

Semnan University of Medical Sciences

Sati.darzi@gmail.com+98 23 3345 1336

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026